Oxbridge Funded 95% of SurancePlus Token Sale, Masking Lack of Independent Demand

Woofun AI reports that SurancePlus, an 80%-owned subsidiary of Oxbridge, executed token sales for products T20 and T42, with significant capital originating from its parent entity rather than external markets. The transaction involved HCI and Fortex Reinsurance, yet the structure obscured the true source of liquidity.

The funding breakdown for these offerings was heavily skewed toward internal capital. Oxbridge contributed approximately $744,623, while third-party investors supplied only $37,143. This resulted in a split where 95.25% of the demand was parent-funded and merely 4.75% came from outside sources. Given that Oxbridge is the 80%-owned controlling entity, the majority of the subscription originated from within the corporate group.

Woofun AI data shows that the filings identify HCI-series purchasers only as "investors," failing to name them or distinguish proceeds between related and unrelated parties. Consequently, the documents do not support counting the $6.323 million as independently verified third-party demand.

Furthermore, the filings do not explain how consolidated accounts eliminated the specific transaction involving the parent-funded subscription, leaving the accounting treatment opaque.

HCI is linked to Oxbridge through common directorship and describes the tokens as synthetic contractual exposure mirroring participations in Fortex Reinsurance's program. This structure does not affect HCI's or Fortex Re's underlying reinsurance arrangements.

However, the lack of purchaser detail prevents verification of independent demand across the full $7.1 million, highlighting significant transparency limitations in the offering.